farnesol has been researched along with transforming growth factor beta in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, JV; Gadbut, AP; Galper, JB; Li, G; Papageorge, AG; Tang, D; Ward, SM; Wu, L | 1 |
| Dushkin, MI; Feofanova, NA; Khoshchenko, OM; Schwartz, YSh | 1 |
| Barkan, B; Ehrlich, M; Kloog, Y | 1 |
| Aizman, E; George, J; Kloog, Y; Levy, A; Mor, A | 1 |
4 other study(ies) available for farnesol and transforming growth factor beta
| Article | Year |
|---|---|
TGFbeta regulates the expression of G alpha(i2) via an effect on the localization of ras.
Topics: Animals; Carbachol; Cardiotonic Agents; Cells, Cultured; Chick Embryo; Enzyme Inhibitors; Farnesol; Gene Expression Regulation, Developmental; GTP-Binding Protein alpha Subunit, Gi2; GTP-Binding Protein alpha Subunits, Gi-Go; Heart Atria; Heart Rate; Methionine; Myocytes, Cardiac; Parasympathetic Nervous System; Promoter Regions, Genetic; Proto-Oncogene Proteins; ras Proteins; Transforming Growth Factor beta | 2002 |
Effects of cholesterol and nuclear hormone receptor agonists on the production of transforming growth factor-beta in macrophages.
Topics: Alitretinoin; Animals; Cells, Cultured; Cholesterol; Farnesol; Hydroxycholesterols; Hydroxysteroids; Ketocholesterols; Lipopolysaccharides; Liver X Receptors; Macrophages; Male; Mevalonic Acid; Mice; Mice, Inbred C57BL; Orphan Nuclear Receptors; Receptors, Cytoplasmic and Nuclear; Retinoid X Receptors; Transforming Growth Factor beta; Tretinoin | 2009 |
Phenotypic reversion of invasive neurofibromin-deficient schwannoma by FTS: Ras inhibition reduces BMP4/Erk/Smad signaling.
Topics: Antineoplastic Agents; Bone Morphogenetic Protein 4; Cell Line, Tumor; Cell Movement; Extracellular Signal-Regulated MAP Kinases; Farnesol; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Models, Biological; Neurilemmoma; Neurofibromin 1; Phenotype; ras Proteins; Salicylates; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2011 |
Ras inhibition by FTS attenuates brain tumor growth in mice by direct antitumor activity and enhanced reactivity of cytotoxic lymphocytes.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Farnesol; Forkhead Transcription Factors; Glioma; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Molecular Targeted Therapy; Oncogene Protein v-akt; Proto-Oncogene Proteins p21(ras); ras Proteins; RNA, Messenger; Salicylates; T-Lymphocytes, Cytotoxic; Transforming Growth Factor beta | 2012 |